AstraZeneca Snuffs Out 'Promise of the Patent' Rule. Now What?
We asked Richard Gold of McGill University's Centre for Intellectual Property Policy to explain what last week's decision from the Supreme Court of Canada means for innovation, competition and patent quality.
By Scott Graham|July 07, 2017
Thank you for sharing!
Your article was successfully shared with the contacts you provided.
In the Goulston & Storrs 2017 General Counsel Survey, fifteen percent of GCs or in-house counsel say they have the most difficulty identifying exposures, and this emerging risk is reshaping their role.
As part of your digital membership, you can sign up for an unlimited number of a wide range of complimentary newsletters.
Visit your My Account page to make your selections. Get the timely legal news and critical analysis you cannot afford to miss.
Tailored just for you. In your inbox. Every day.